These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20811072)

  • 1. Cost-saving tree-structured survival analysis for hip fracture of study of osteoporotic fractures data.
    Jin H; Lu Y
    Med Decis Making; 2011; 31(2):299-307. PubMed ID: 20811072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative tree-structured survival analysis based on variance of survival time.
    Jin H; Lu Y; Stone K; Black DM
    Med Decis Making; 2004; 24(6):670-80. PubMed ID: 15534347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs.
    Sander B; Elliot-Gibson V; Beaton DE; Bogoch ER; Maetzel A
    J Bone Joint Surg Am; 2008 Jun; 90(6):1197-205. PubMed ID: 18519311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification algorithms for hip fracture prediction based on recursive partitioning methods.
    Jin H; Lu Y; Harris ST; Black DM; Stone K; Hochberg MC; Genant HK
    Med Decis Making; 2004; 24(4):386-98. PubMed ID: 15271277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of osteoporotic fractures: a method for setting intervention thresholds.
    Kanis JA; Oden A; Johnell O; Jonsson B; de Laet C; Dawson A
    Osteoporos Int; 2001; 12(5):417-27. PubMed ID: 11444092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.
    Daruwalla ZJ; Huq SS; Wong KL; Nee PY; Leong KM; Pillay KR; Murphy DP
    Osteoporos Int; 2016 Jan; 27(1):361-6. PubMed ID: 26510846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-equivalence of different osteoporotic fractures.
    Melton LJ; Gabriel SE; Crowson CS; Tosteson AN; Johnell O; Kanis JA
    Osteoporos Int; 2003 Jun; 14(5):383-8. PubMed ID: 12730750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients.
    Makridis KG; Karachalios T; Kontogeorgakos VA; Badras LS; Malizos KN
    Injury; 2015 Feb; 46(2):378-83. PubMed ID: 25541417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sarcopenia in the risk of osteoporotic hip fracture.
    Oliveira A; Vaz C
    Clin Rheumatol; 2015 Oct; 34(10):1673-80. PubMed ID: 25912213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
    Gabriel SE; Kneeland TS; Melton LJ; Moncur MM; Ettinger B; Tosteson AN
    Med Decis Making; 1999; 19(2):141-8. PubMed ID: 10231076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits.
    Bendich A; Leader S; Muhuri P
    Clin Ther; 1999 Jun; 21(6):1058-72. PubMed ID: 10440627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dedicated Perioperative Hip Fracture Comanagement Programs are Cost-effective in High-volume Centers: An Economic Analysis.
    Swart E; Vasudeva E; Makhni EC; Macaulay W; Bozic KJ
    Clin Orthop Relat Res; 2016 Jan; 474(1):222-33. PubMed ID: 26260393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Absolute risk for fracture and WHO guideline. Economic analysis of pharmacotherapy for osteoporosis].
    Harada A;
    Clin Calcium; 2007 Jul; 17(7):1029-34. PubMed ID: 17607069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost analysis of osteoporotic hip fractures.
    Woratanarat P; Wajanavisit W; Lertbusayanukul C; Loahacharoensombat W; Ongphiphatanakul B
    J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S96-104. PubMed ID: 16869109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on direct economic-burden and its risk factors of osteoporotic hip fracture].
    Luo LZ; Xu L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Sep; 26(9):669-72. PubMed ID: 16471214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for osteoporotic hip fractures in Mexicans.
    Clark P; de la Peña F; Gómez García F; Orozco JA; Tugwell P
    Arch Med Res; 1998; 29(3):253-7. PubMed ID: 9775460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.
    Lippuner K; Johansson H; Kanis JA; Rizzoli R
    Osteoporos Int; 2009 Jul; 20(7):1131-40. PubMed ID: 18974918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic cost of osteoporotic hip fractures in Singapore.
    Lee YH; Lim YW; Lam KS
    Singapore Med J; 2008 Dec; 49(12):980-4. PubMed ID: 19122947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.